Work with thought leaders and academic experts in endocrinology diabetes metabolism

Companies can greatly benefit from working with experts in the field of Endocrinology, Diabetes, and Metabolism. These researchers possess in-depth knowledge and understanding of the complex mechanisms underlying endocrine disorders and metabolic diseases. By collaborating with them, companies can gain valuable insights for developing innovative treatments, drugs, and medical devices. They can also provide expert guidance in clinical trials, ensuring the safety and efficacy of new interventions. Additionally, these researchers can contribute to the development of personalized medicine approaches, helping companies tailor treatments to individual patients. Overall, partnering with Endocrinology, Diabetes, and Metabolism experts can accelerate research, enhance product development, and improve patient outcomes.

Experts on NotedSource with backgrounds in endocrinology diabetes metabolism include Dushani L. Palliyaguru, Ph.D., Daniel Milej, Ph.D., Sonja Lyubomirsky, Giuliana Noratto, Eric S. Kim, Ph.D., Bernd Stahl, Matthew Laye, Ph.D., Joel Prowting, Dr. Kevin Pawlak, Ph.D., Daniel Sibley, Andrew Mikhail, Brad Currier, Massimo Nardone, Patrick Reeson, Mehrdad Sheikhvatan, Nicolas Collao, and Caroline Doyle, Ph.D..

Eric S. Kim, Ph.D.

Assistant Professor of Psychology, University of British Columbia
Most Relevant Research Interests
Other Research Interests (41)
health psychology
social epidemiology
purpose & meaning
And 36 more
Dr. Kim's program of research aims to identify, understand, and intervene upon the dimensions of psychological well-being (sense of purpose in life, optimism) that reduce the risk of age-related conditions. <br> Around this topic, he has given invited lectures at Universities (Harvard, U. of Penn, MIT, Columbia U.), corporations (UnitedHealth Care, IDEO, AARP, Samsung), and he’s also been invited to speak at and join the working groups of national- and international-think-tanks (United Nations, OECD, Aspen Ideas Festival, Chan Zuckerberg Initiative, The Task Force for Global Health, World Government Summit, National Academy of Sciences). He’s also been recognized as one of Forbe’s 30 Under 30 in Healthcare, recipient of the American Journal of Epidemiology's Paper of the Year Award, the American Psychological Association Division 20 (Aging) Early Career Achievement Award, and an Association for Psychological Science (APS) Rising Star. His insights have been featured in the: NY Times, Atlantic, BBC News, NPR, Washington Post. His research has been cited by policy statements/guidelines formulated by the: United Nations, National Academy of Sciences, American Heart Association, the U.S. Surgeon General. Population aging is one of the most important social trends of the 21st century. In both Canada and the U.S., the # of adults aged ≥65 is projected to increase by 45%-55% in the next 15 years. As societies grapple with the rising tide of chronic conditions, healthcare costs, and long-term care costs, it is imperative to develop a science that informs a more comprehensive approach to healthy aging. Dr. Kim’s overarching goal is to substantially help improve the psychological well-being and physical health of our rapidly growing population. In pursuit of this goal, his program of research revolves around 4 interwoven questions. He studies: 1) Several dimensions of psychological well-being (sense of purpose in life, optimism) and how they relate to health outcomes. 2) The behavioral, biological, and neural mechanisms underlying the association between psychological well-being and health. 3) How an individual’s psychological well-being interacts with the surrounding environment to influence behavioral and physical health outcomes; for example, at the meso-level (dyadic dynamics in couples, neighborhood contexts, altruism/volunteering) and the macro-level (social cohesion, social and racial disparities). 4) And he partners with non-profit/healthcare companies to conduct translational research that test scalable interventions.

Example endocrinology diabetes metabolism projects

How can companies collaborate more effectively with researchers, experts, and thought leaders to make progress on endocrinology diabetes metabolism?

Development of novel diabetes medications

An academic researcher in Endocrinology, Diabetes, and Metabolism can collaborate with pharmaceutical companies to develop new and more effective medications for diabetes. Their expertise in understanding the underlying mechanisms of the disease can help identify novel drug targets and design innovative therapeutic approaches.

Advancement of insulin delivery systems

Companies specializing in medical devices can collaborate with Endocrinology, Diabetes, and Metabolism researchers to advance insulin delivery systems. These experts can provide insights into optimizing insulin administration, improving device usability, and developing innovative technologies such as closed-loop systems.

Research on hormonal regulation and obesity

Companies focused on obesity management can benefit from collaborating with researchers in Endocrinology, Diabetes, and Metabolism. Their expertise in hormonal regulation and metabolic pathways can contribute to the development of effective interventions for obesity prevention and treatment.

Development of diagnostic tools for endocrine disorders

Endocrinology, Diabetes, and Metabolism experts can collaborate with diagnostic companies to develop accurate and efficient tools for diagnosing endocrine disorders. Their deep understanding of hormone levels, biomarkers, and disease patterns can aid in the creation of reliable diagnostic tests.

Clinical trial design and expertise

Pharmaceutical companies conducting clinical trials can partner with academic researchers in Endocrinology, Diabetes, and Metabolism to design and oversee trials. These experts can provide valuable insights into patient selection, study endpoints, and data analysis, ensuring the success and validity of the trials.